Browsing by Yonsei Author : Kim, Joo Hang

eperson profile image
Name:
Kim, Joo Hang [김주항]
Department :
College of Medicine (의과대학) - Dept. of Internal Medicine (내과학교실)

Keyword Cloud

Researcher Network

Showing results 51 to 100 of 200

This table browses all dspace content
Issue DateTitleJournal Title
2012High EGFR gene copy number and skin rash as predictive markers for EGFR tyrosine kinase inhibitors in patients with advanced squamous cell lung carcinoma. CLINICAL CANCER RESEARCH
2012HSP27 modulates survival signaling networks in cells treated with curcumin and TRAIL.CELLULAR SIGNALLING
2012The efficacy and toxicity of S-1 and cisplatin as first-line chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma.CANCER CHEMOTHERAPY AND PHARMACOLOGY
2012Distinct clinical features and outcomes in never-smokers with nonsmall cell lung cancer who harbor EGFR or KRAS mutations or ALK rearrangement. CANCER
2012Additional diagnostic value of tumor markers in cytological fluid for diagnosis of non-small-cell lung cancer BMC CANCER
2012Phase II study of cisplatin with irinotecan as induction chemotherapy followed by chemoradiotherapy for unresectable stage III non-small cell lung cancerANTICANCER RESEARCH
2011A randomized phase 3 trial comparing pemetrexed/carboplatin and docetaxel/carboplatin as first-line treatment for advanced, nonsquamous non-small cell lung cancerJOURNAL OF THORACIC ONCOLOGY
2011Comparative effectiveness of bevacizumab plus cisplatin-based chemotherapy versus pemetrexed plus cisplatin treatment in East Asian non-squamous non-small cell lung cancer patients applying real-life outcomesASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY
2011Cost-effectiveness of bevacizumab-based therapy versus cisplatin plus pemetrexed for the first-line treatment of advanced non-squamous NSCLC in Korea and TaiwanASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY
2011An indirect comparison of bevacizumab plus cisplatin-gemcitabine and cisplatin plus pemetrexed treatment for patients with advanced first-line non-squamous non-small cell lung cancer in East Asia.ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY
2011Prognostic and predictive value of CEA and CYFRA 21-1 levels in advanced non-small cell lung cancer patients treated with gefitinib or erlotinib. EXPERIMENTAL AND THERAPEUTIC MEDICINE
2011Analysis of tumor markers in the cytological fluid obtained from computed tomography-guided needle aspiration biopsy for the diagnosis of non-small cell lung cancerJOURNAL OF THORACIC ONCOLOGY
2011A phase I study of nimotuzumab in combination with radiotherapy in stages IIB-IV non-small cell lung cancer unsuitable for radical therapy: Korean results.LUNG CANCER
2011Lung cancer in never smokers: change of a mindset in the molecular era.LUNG CANCER
2011MEKK1/MEKK4 are responsible for TRAIL-induced JNK/p38 phosphorylation ONCOLOGY REPORTS
2011TRAIL-induced caspase/p38 activation is responsible for the increased catalytic and invasive activities of Akt INTERNATIONAL JOURNAL OF ONCOLOGY
2010Prognostic factors in small cell lung cancer: a new prognostic index in Korean patientsONCOLOGY
2010Dose effect of cigarette smoking on frequency and spectrum of epidermal growth factor receptor gene mutations in Korean patients with non-small cell lung cancer.JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
2010Randomized Phase III trial of gefitinib versus docetaxel in non-small cell lung cancer patients who have previously received platinum-based chemotherapy CLINICAL CANCER RESEARCH
2010Belotecan for relapsing small-cell lung cancer patients initially treated with an irinotecan-containing chemotherapy: a phase II trialLUNG CANCER
2010Paclitaxel combined with ifosfamide in anthracycline- and docetaxel-pretreated metastatic breast cancer: activity independence of prior docetaxel resistanceCANCER CHEMOTHERAPY AND PHARMACOLOGY
2010Acquired resistance to cetuximab is mediated by increased PTEN instability and leads cross-resistance to gefitinib in HCC827 NSCLC cells.CANCER LETTERS
2010Therapeutic and tumor-specific immunity induced by combination of dendritic cells and oncolytic adenovirus expressing IL-12 and 4-1BBL MOLECULAR THERAPY
2010Frequent central nervous system failure after clinical benefit with epidermal growth factor receptor tyrosine kinase inhibitors in Korean patients with nonsmall-cell lung cancer. CANCER
2010Weekly 5-fluorouracil plus cisplatin for concurrent chemoradiotherapy in patients with locally advanced head and neck cancerHEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
2010Impact of environmental tobacco smoke on the incidence of mutations in epidermal growth factor receptor gene in never-smoker patients with non-small-cell lung cancer.JOURNAL OF CLINICAL ONCOLOGY
2010The role of monoclonal antibody in combination with first-line chemotherapy in Asian patients with advanced non-small cell lung cancer YONSEI MEDICAL JOURNAL
2009Complete response of recurrent squamous cell carcinoma of the lung: dose the dose matter?JOURNAL OF THORACIC ONCOLOGY
2009Brain metastases from hepatocellular carcinoma: prognostic factors and outcome: brain metastasis from HCCJOURNAL OF NEURO-ONCOLOGY
2009Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 studyLANCET
2009Adenosine triphosphate-based chemotherapy response assay (ATP-CRA)-guided versus empirical chemotherapy in unresectable non-small cell lung cancer ANTICANCER RESEARCH
2009비소세포성 폐암으로 수술 후 방사선치료가 시행된 N2병기 환자들에서 다발 부위 종격동 림프절 전이 여부에 따른 N2병기 구분의 임상적 의미 Journal of the Korean Society for Therapeutic Radiology and Oncology
2009Weekly docetaxel in patients with platinum-refractory metastatic or recurrent squamous cell carcinoma of the head and neckCANCER CHEMOTHERAPY AND PHARMACOLOGY
2009Double E1B 19 kDa- and E1B 55 kDa-deleted oncolytic adenovirus in combination with radiotherapy elicits an enhanced anti-tumor effectGENE THERAPY
2009High tumor metabolic activity as measured by fluorodeoxyglucose positron emission tomography is associated with poor prognosis in limited and extensive stage small-cell lung cancer. CLINICAL CANCER RESEARCH
2009Activating mutations within the EGFR kinase domain: a molecular predictor of disease-free survival in resected pulmonary adenocarcinoma.JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
2009Phase II study of transarterial holmium-166-chitosan complex treatment in patients with a single, large hepatocellular carcinomaONCOLOGY
2008The number of residual metastatic lymph nodes following neoadjuvant chemotherapy predicts survival in patients with stage III NSCLC.LUNG CANCER
2008Short hairpin RNA-expressing oncolytic adenovirus-mediated inhibition of IL-8: effects on antiangiogenesis and tumor growth inhibitionGENE THERAPY
2008Novel cancer antiangiotherapy using the VEGF promoter-targeted artificial zinc-finger protein and oncolytic adenovirusMOLECULAR THERAPY
2008Combination of topotecan and etoposide as a salvage treatment for patients with recurrent small cell lung cancer following irinotecan and platinum first-line chemotherapy.CANCER CHEMOTHERAPY AND PHARMACOLOGY
2008A single institutional experience of surgically resected thymic epithelial tumors over 10 years: clinical outcomes and clinicopathologic featuresONCOLOGY REPORTS
2008Chemoradiotherapy with or without consolidation chemotherapy using cisplatin and 5-fluorouracil in anal squamous cell carcinoma: long-term results in 31 patients BMC CANCER
2007Multi-disciplinary treatment of a rare pelvic cavity ependymoma YONSEI MEDICAL JOURNAL
2007VEGF-specific short hairpin RNA-expressing oncolytic adenovirus elicits potent inhibition of angiogenesis and tumor growthMOLECULAR THERAPY
2007Retargeting of adenoviral gene delivery via Herceptin-PEG-adenovirus conjugates to breast cancer cellsJOURNAL OF CONTROLLED RELEASE
2007Phase II study of erlotinib in advanced non-small-cell lung cancer after failure of gefitinibJOURNAL OF CLINICAL ONCOLOGY
2007Clinical significance of cyclooxygenase-2 expression in extranodal natural killer (NK)/T-cell lymphoma, nasal typeINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2007E1A- and E1B-double mutant replicating adenovirus elicits enhanced oncolytic and antitumor effectsHUMAN GENE THERAPY
2007Treatment outcomes of 70 cases of early esophageal carcinoma: 12 years of experienceDISEASES OF THE ESOPHAGUS

Browse

Links